Johnson & Johnson has signed with the US authorities agreement to supply 100 million doses of vaccines against coronavirus infection in case of its successful research and registration. Under the agreement, the company will receive $ 1 billion, writes Reuters.
This is the first agreement with Johnson & Johnson about the delivery of an experimental vaccine to the country. Currently, the negotiations on the issue are held with the authorities of the EU, but a final agreement has not been reached.
Previously, the US government has concluded agreements on the supply of vaccine development Sanofi and GlaxoSmithKline, and Pfizer development and BioNTech. In these cases, the value of the contracts was estimated at approximately $ 2 billion.